EU opinion & policy debates - across languages | BlogActiv.eu

Archives for Health & Consumers

Genval, 24 April, 2016. – Disclaimer: These are the transcripts of an interview originally published on International Innovation (issue 163) in November 2014. The authentic version is available at the International Innovation website. How to improve the health status and life expectancy of Europe’s population while reducing health inequalities? Overview of my work as a… » read more

  Posted by EU ZMK's Diary

Genval, 16th April 2016 – Ironic. While there are – at least – three, “low hanging fruit” type policy proposal on the table for the European Commission to improve population health in the EU, we can only expect a 1 day conference on chronic diseases. Talk shaw or real action, this is the question. ‘Towards… » read more

  Posted by EU ZMK's Diary

Genval, 11th April 2016. – Because trade secret is so widely defined that it includes clinical trials data, and despite of vague exceptions, it can well affect clinical trials transparency which is key for patient safety and new drug development. There is no guarantuee that Pharmaceutical companies will not abuse it. Why are Trade Secrets… » read more

  Posted by EU ZMK's Diary

Genval, 4th April, 2016 – Yes, it would, because – strangely enough – this time the industry is asking for more regulation: public health and consumer protection NGOs are united with processed food industry giants on the ban of industrially produced trans fats. Since this is a strange alliance of organisations usually having conflicting (private… » read more

  Posted by EU ZMK's Diary

Genval, 30 March, 2016. – Disclaimer: This is the English translation of an interview made by Mihail Călin and originally published on 25 September 2015. The authentic Romanian version is available at the euro-health.ro News/Media website. The Transatlantic Trade and Investment Partnership (TTIP) between the United States and the EU are surrounded by fierce controversy… » read more

  Posted by EU ZMK's Diary

  Two studies came out (just in time for Pesticide Action Week) that question the cost to society of pesticides and other chemicals. The logic is simple: Chemicals cost societies billions of dollars, therefore removing them would save money. I am a little troubled by such a simplistic view – like any statistical analysis, you… » read more

  Posted by The Risk-Monger

  The last blog looked at ten reasons why glyphosate is the herbicide of the century. So why then, despite the overwhelming scientific evidence and clear environmental and social benefits, is this product on the verge of having its authorisation removed? The NGO activists and pro-organic lobbyists have led a formidable campaign that started a… » read more

  Posted by The Risk-Monger

The following is the first of a two-part blog looking at how a corrupt unethical campaign against an essential agricultural product is succeeding in the EU. This first part will look at why glyphosate is such a good product for farmers; the second part will demonstrate how environmental NGOs, activist scientists, organic lobbyists and IARC… » read more

  Posted by The Risk-Monger

Guest blog post by Professor Stephen Holgate, Science Council Chair for the European Respiratory Society; and Professor Bruno Crestani, Conferences and Seminars Director for the European Respiratory Society. If you are ill, imagine that you could visit a doctor who can deliver an efficient, targeted, personalised treatment programme that is adjusted to your body and… » read more

  Posted by The Guest Blog

Genval, 8th March 2016. – The European Parliament is about to vote tomorrow on a tobacco agreement between the EU and Philipp Morris International (PMI) and it is at least questionable that the EU’s intention is legal, ethical or politically correct. At the same bed with the ennemy? From a legal point of view, according… » read more

  Posted by EU ZMK's Diary

Guest blog post by Carlos Lines Millán, President of the European Idiopathic Pulmonary Fibrosis & Related Disorders Federation (EU-IPFF). Idiopathic Pulmonary Fibrosis (IPF) is a rare but devastating, irreversible and chronic disease affecting around 100,000 Europeans. The causes are unknown, no universal cure exists, it is only ever manageable and those seeking a lung transplant… » read more

  Posted by The Guest Blog

Will TTIP Make Europe Sick?

Genval, 28th February 2016 – Right after the 12th Transatlantic Trade and Investment Partnership (TTIP) Brussels negotiations round, it is still unclear if the deadly link between increased trade of alcohol, tobacco and unhealthy food and the growing economic and societal burden of Chronic Non Communicable Diseases (NCDs) is recongised. While both side of the… » read more

  Posted by EU ZMK's Diary

  For the last twelve years, I have taught courses on Corporate Communications and Public Relations mostly to university law students. Towards the end of the course, after following a company’s communications activities for around three months, I poll my students on the class forum, asking if they could imagine working for their chosen corporations.… » read more

  Posted by The Risk-Monger

Genval, 31st January 2016. – Is it really apropriate to raise this question, after the European Parliament’s Legal Affairs (JURI) Committee has endorsed a trilogue deal with the Council on Trade Secrets with an overwhelming political majority (EPP-S&D-ECR-ALDE-EFDD-ENF(!))? I think it is as I believe some of the key public interest concerns were not taken… » read more

  Posted by EU ZMK's Diary

EurActiv Network